Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37385251.
- Also identified by DOI 10.1016/j.stem.2023.06.002 and PMC identifier 10338855.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Gene editing using engineered nucleases frequently produces unintended genetic lesions in hematopoietic stem cells (HSCs). Gene-edited HSC cultures thus contain heterogeneous populations, the majority of which either do not carry the desired edit or harbor unwanted mutations. In consequence, transplanting edited HSCs carries the risks of suboptimal efficiency and of unwanted mutations in the graft. Here, we present an approach for expanding gene-edited HSCs at clonal density, allowing for genetic profiling of individual clones before transplantation. We achieved this by developing a defined, polymer-based expansion system and identifying long-term expanding clones within the CD201<sup>+</sup>CD150<sup>+</sup>CD48<sup>-</sup>c-Kit<sup>+</sup>Sca-1<sup>+</sup>Lin<sup>-</sup> population of precultured HSCs. Using the Prkdc<sup>scid</sup> immunodeficiency model, we demonstrate that we can expand and profile edited HSC clones to check for desired and unintended modifications, including large deletions. Transplantation of Prkdc-corrected HSCs rescued the immunodeficient phenotype. Our ex vivo manipulation platform establishes a paradigm to control genetic heterogeneity in HSC gene editing and therapy.
Medical subject headings
- Gene Editing
- Hematopoietic Stem Cell Transplantation